|
|
ICU患者多重耐药菌医院感染基本状况及防控措施
|
Abstract:
重症监护室(ICU)是多重耐药菌感染的高发科室，多重耐药菌感染与多种因素有关，早期进行风险识别、严格落实各环节是做好多重耐药菌感染防控工作的关键。近年来，医院感染问题层出不穷，管理层对在持续加强对医院感染的防控。本文介绍了ICU患者多重耐药菌的种类，MRDO感染类型及危险因素，简述了多重耐药菌感染的管理方法和防控措施。旨在为ICU患者多重耐药医院感染的防控提供参考。
Intensive care unit (ICU) is a high incidence department of multi-drug resistant bacteria infection, multi-drug resistant bacteria infection is related to a variety of factors, early risk identification, strict implementation of each link is the key to do a good job in the prevention and control of mul-ti-drug resistant bacteria infection. In recent years, the problem of nosocomial infection has emerged endlessly, and the management continues to strengthen the prevention and control of nosocomial infection. This paper introduces the types of multi-drug resistant bacteria, MRDO infec-tion types and risk factors in ICU patients, and briefly describes the management methods and prevention and control measures of multi-drug resistant bacteria infection. The aim is to provide reference for the prevention and control of multi-drug resistant nosocomial infection in ICU pa-tients.
| [1] | 王妍妍, 蒋昭清, 冯丹丹, 等. 医院获得性革兰氏阴性杆菌血流感染的耐药性及预后影响因素分析[J]. 浙江临床医学, 2022, 24(2): 216-219. |
| [2] | Zhao, S., Wu, Y., Dai, Z., et al. (2022) Risk Factors for Antibiotic Resistance and Mortality in Patients with Bloodstream Infection of Escherichia coli. European Journal of Clinical Microbiology & Infec-tious Diseases: Official Publication of the European Society of Clinical Microbiology, 41, 713-721. https://doi.org/10.1007/s10096-022-04423-6 |
| [3] | Alwazzeh, M.J., Alnimr, A., Al Nassri, S.A., et al. (2023) Mi-crobiological Trends and Mortality Risk Factors of Central Line-Associated Bloodstream Infections in an Academic Medical Center 2015-2020. Antimicrobial Resistance & Infection Control, 12, Article No. 128. https://doi.org/10.1186/s13756-023-01338-5 |
| [4] | Firoozeh, N., Agah, E., Bauer, Z.A., et al. (2022) Cathe-ter-Associated Urinary Tract Infection in Neurological Intensive Care Units: A Narrative Review. The Neurohospitalist, 12, 484-497. https://doi.org/10.1177/19418744221075888 |
| [5] | 中华人民共和国卫生部. 医院感染诊断标准(试行) [J]. 中华医学杂志, 2001, 81(5): 314-320. |
| [6] | Al-Tawfiq, J.A. and Tambyah, P.A. (2014) Healthcare Associated Infections (HAI) Perspectives. Journal of Infection and Public Health, 7, 339-344. https://doi.org/10.1016/j.jiph.2014.04.003 |
| [7] | Magill, S.S., O’Leary, E., Janelle, S.J., et al. (2018) Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. The New England Journal of Medicine, 379, 1732-1744. https://doi.org/10.1056/NEJMoa1801550 |
| [8] | 中华人民共和国卫生部. 多重耐药菌医院感染预防与控制技术指南(试行) [S]. 北京: 中华人民共和国卫生部, 2012. |
| [9] | Tacconelli, E., Carrara, E., Savoldi, A., et al. (2018) Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bac-teria and Tuberculosis. The Lancet Infectious Diseases, 18, 318-327.
https://doi.org/10.1016/S1473-3099(17)30753-3 |
| [10] | 黄勋, 邓子德, 倪语星, 等. 多重耐药菌医院感染预防与控制中国专家共识[J]. 中国感染控制杂志, 2015, 14(1): 1-9. |
| [11] | 陈佰义, 何礼贤, 胡必杰, 等. 中国鲍曼不动杆菌感染诊治与防控专家共识[J]. 中国医药科学, 2012, 2(8): 3-8. |
| [12] | Khodamoradi, Y., Kessel, J., Janne Vehreschild, J., et al. (2019) The Role of Microbiota in Preventing Multidrug-Resistant Bacterial Infections. Deutsches ？rzteblatt International, 116, 670-676.
https://doi.org/10.3238/arztebl.2019.0670 |
| [13] | Mirande, C., Bizine, I., Giannetti, A., et al. (2018) Epidemiological Aspects of Healthcare-Associated Infections and Microbial Genomics. European Journal of Clinical Microbiology & In-fectious Diseases: Official Publication of the European Society of Clinical Microbiology, 37, 823-831. https://doi.org/10.1007/s10096-017-3170-x |
| [14] | Litwin, A., Fedorowicz, O. and Duszynska, W. (2020) Character-istics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018. International Journal of Environ-mental Research and Public Health, 17, Article No. 6943. https://doi.org/10.3390/ijerph17196943 |
| [15] | 唐朋, 邱宗文, 全念, 等. 重庆市某三甲综合医院2020年细菌耐药性监测[J]. 国际检验医学杂志, 2022, 43(20): 2452-2457. |
| [16] | 王艳红, 刘艳红. 重症监护病房多重耐药菌的感染类型、耐药机制、耐药性及感染相关因素分析[J]. 吉林医学, 2019, 40(9): 2077-2078. |
| [17] | Abdalla, J.S., Albarrak, M., Alhasawi, A., et al. (2023) Narrative Re-view of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries. Infectious Diseases and Therapy, 12, 1741-1773. https://doi.org/10.1007/s40121-023-00834-w |
| [18] | Fumagalli, J., Panigada, M., Klompas, M., et al. (2022) Venti-lator-Associated Pneumonia among SARS-CoV-2 Acute Respiratory Distress Syndrome Patients. Current Opinion in Critical Care, 28, 74-82.
https://doi.org/10.1097/MCC.0000000000000908 |
| [19] | Pickens, C.O., Gao, C.A., Cuttica, M.J., et al. (2021) Bac-terial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia. American Journal of Respiratory and Critical Care Medicine, 204, 921-932.
https://doi.org/10.1164/rccm.202106-1354OC |
| [20] | Papazian, L., Klompas, M. and Luyt, C.E. (2020) Ventila-tor-Associated Pneumonia in Adults: A Narrative Review. Intensive Care Medicine, 46, 888-906. https://doi.org/10.1007/s00134-020-05980-0 |
| [21] | Ahmadipour, M., Lashkari, M. and Ahmadinejad, M. (2023) Comparison of Morbidity, Mortality, and Costs of VAP Patients with Non-VAP Patients in the Tertiary Referral Hospi-tal of Kerman, Iran. Tanaffos, 22, 61-69. |
| [22] | Wicky, P.H., Dupuis, C., Cerf, C., et al. (2023) Ventilator-Associated Pneumonia in COVID-19 Patients Admitted in Intensive Care Units: Relapse, Therapeutic Failure and Attributable Mor-tality—A Multicentric Observational Study from the OUTCOMEREA Network. Journal of Clinical Medicine, 12, Arti-cle No. 1298.
https://doi.org/10.3390/jcm12041298 |
| [23] | Fernando, S.M., Tran, A., Cheng, W., et al. (2020) Diagnosis of Venti-lator-Associated Pneumonia in Critically Ill Adult Patients—A Systematic Review and Meta-Analysis. Intensive Care Medicine, 46, 1170-1179.
https://doi.org/10.1007/s00134-020-06036-z |
| [24] | Hou, Y., Griffin, L., Bernatchez, S.F., et al. (2023) Comparative Effectiveness of 2 Chlorhexidine Gluconate-Con- taining Dressings in Reducing Central Line-Associated Bloodstream Infections, Hospital Stay, and Costs. Inquiry: A Journal of Medical Care Organization, Provision and Financing, 60. https://doi.org/10.1177/00469580231214751 |
| [25] | Liu, J.Y. and Dickter, J.K. (2020) Nosocomial Infections: A History of Hospital-Acquired Infections. Gastrointestinal Endoscopy Clinics of North America, 30, 637-652. https://doi.org/10.1016/j.giec.2020.06.001 |
| [26] | 尹楠. 中心静脉导管血流感染的相关影响因素分析[J]. 国际医药卫生导报, 2021, 27(3): 382-384. |
| [27] | Obaid, N.A. (2021) Preventive Measures and Management of Cathe-ter-Associated Urinary Tract Infection in Adult Intensive Care Units in Saudi Arabia. Journal of Epidemiology and Global Health, 11, 164-168.
https://doi.org/10.2991/jegh.k.210418.001 |
| [28] | Rosenthal, V.D., Bat-Erdene, I., Gupta, D., et al. (2020) Interna-tional Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 45 Countries for 2012-2017: De-vice-Associated Module. American Journal of Infection Control, 48, 423-432. https://doi.org/10.1016/j.ajic.2019.08.023 |
| [29] | Rosenthal, V.D., Duszynska, W., Ider, B.E., et al. (2021) Interna-tional Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 45 Countries for 2013-2018, Adult and Pediatric Units, Device-Associated Module. American Journal of Infection Control, 49, 1267-1274. https://doi.org/10.1016/j.ajic.2021.04.077 |
| [30] | Spigaglia, P. (2022) Clostridioides difficile Infection (CDI) during the COVID-19 Pandemic. Anaerobe, 74, Article ID: 102518. https://doi.org/10.1016/j.anaerobe.2022.102518 |
| [31] | CDC and U.S. Department of Health and Human Services (2019) Antibiotic Resistance Threats in the United States. |
| [32] | Singh, T., Bedi, P., Bumrah, K., et al. (2019) Updates in Treatment of Recurrent Clostridium difficile Infection. Journal of Clinical Medicine Research, 11, 465-471. https://doi.org/10.14740/jocmr3854 |
| [33] | Antonelli, M., Martin-Loeches, I., Dimopoulos, G., et al. (2020) Clos-tridioides difficile (Formerly Clostridium difficile) Infection in the Critically Ill: An Expert Statement. Intensive Care Medicine, 46, 215-224.
https://doi.org/10.1007/s00134-019-05873-x |
| [34] | Guery, B., Barbut, F. and Tschudin-Sutter, S. (2020) Diagnostic and Therapy of Severe Clostridioides difficile Infections in the ICU. Current Opinion in Critical Care, 26, 450-458. https://doi.org/10.1097/MCC.0000000000000753 |
| [35] | Lin, L., Wang, R., Chen, T., et al. (2021) Failure Mode and Effects Analysis on the Control Effect of Multi-Drug-Re- sistant Bacteria in ICU Patients. American Journal of Transla-tional Research, 13, 10777-10784. |
| [36] | 林露, 张菊, 李刚, 等. 失效模式与效应分析联合PDCA循环在重症监护病房多重耐药菌院内感染防控中的应用[J]. 华西医学, 2022, 37(3): 363-368. |
| [37] | Majumder, M.A.A., Rahman, S., Cohall, D., et al. (2020) Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health. Infection and Drug Resistance, 13, 4713-4738.
https://doi.org/10.2147/IDR.S290835 |
| [38] | 吴睿, 许斯, 张艳, 等. 重症监护病房高频接触表面清洁消毒干预效果评价[J]. 中华医院感染学杂志, 2018, 28(19): 3026-3028. |
